Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clin |
RCV000984203 | SCV001250552 | uncertain significance | Phenylketonuria | 2020-01-26 | reviewed by expert panel | curation | The c.757G>A (p.Asp253Asn) variant in PAH has not been reported in the literature to our knowledge. This variant has an extremely low frequency in ExAC and gnomAD (MAF=0.00001). Multiple lines of computational evidence support a deleterious effect. In summary, this variant meets criteria to be classified as uncertain significance for PAH. PAH-specific ACMG/AMP criteria applied: PM2, PP3. |
Gene |
RCV000484615 | SCV000571414 | likely pathogenic | not provided | 2016-08-15 | criteria provided, single submitter | clinical testing | The D253N missense variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The D253N variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The D253N variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is conserved across species and in silico analysis predicts this variant is probably damaging to the protein structure/function. In summary, we interpret D253N as likely pathogenic. |
Counsyl | RCV000984203 | SCV001132265 | uncertain significance | Phenylketonuria | 2017-08-08 | no assertion criteria provided | clinical testing |